CA2945705A1 - Methods for treating hypersomnia - Google Patents
Methods for treating hypersomnia Download PDFInfo
- Publication number
- CA2945705A1 CA2945705A1 CA2945705A CA2945705A CA2945705A1 CA 2945705 A1 CA2945705 A1 CA 2945705A1 CA 2945705 A CA2945705 A CA 2945705A CA 2945705 A CA2945705 A CA 2945705A CA 2945705 A1 CA2945705 A1 CA 2945705A1
- Authority
- CA
- Canada
- Prior art keywords
- ptz
- hypersomnia
- subject
- administered
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461979918P | 2014-04-15 | 2014-04-15 | |
| US61/979,918 | 2014-04-15 | ||
| PCT/US2015/025696 WO2015160766A1 (en) | 2014-04-15 | 2015-04-14 | Methods for treating hypersomnia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2945705A1 true CA2945705A1 (en) | 2015-10-22 |
Family
ID=54324484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2945705A Abandoned CA2945705A1 (en) | 2014-04-15 | 2015-04-14 | Methods for treating hypersomnia |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10688103B2 (enExample) |
| EP (1) | EP3131904A4 (enExample) |
| JP (2) | JP6672264B2 (enExample) |
| KR (1) | KR20170005415A (enExample) |
| CN (1) | CN106459066B (enExample) |
| AU (2) | AU2015247829B2 (enExample) |
| CA (1) | CA2945705A1 (enExample) |
| EA (1) | EA201692061A1 (enExample) |
| IL (1) | IL248255A0 (enExample) |
| MX (1) | MX2016013340A (enExample) |
| WO (1) | WO2015160766A1 (enExample) |
| ZA (1) | ZA201607068B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10278977B2 (en) | 2016-06-06 | 2019-05-07 | Umecrine Cognition Ab | Methods for treating hypersomnolence |
| US11529358B2 (en) | 2017-05-10 | 2022-12-20 | Emory University | Treatment of conditions associated with myotonic dystrophy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006137746A (ja) | 2004-10-13 | 2006-06-01 | Otsuka Pharmaceut Factory Inc | オレキシン誘導組成物 |
| CA2686155C (en) | 2006-05-22 | 2016-11-15 | The Board Of Trustees Of The Leland Stanford Junior University | Pharmacological treatment of cognitive impairment |
| JP2010515882A (ja) * | 2007-01-05 | 2010-05-13 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 睡眠関連障害を含むｇａｂａ関連神経学的障害を処置するためのｇタンパク質共役受容体およびその調節因子 |
| US9616070B2 (en) * | 2008-03-12 | 2017-04-11 | Emory University | Use of GABAA receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness |
| US20090325999A1 (en) * | 2008-06-27 | 2009-12-31 | Jie Du | Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions |
| US8946206B2 (en) * | 2010-12-17 | 2015-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for improving cognitive function |
| JP2014511382A (ja) | 2011-02-23 | 2014-05-15 | コエルルウス リミテッド | フルマゼニル錯体、それを含む組成物、およびその使用 |
| ES2579319T3 (es) | 2011-05-04 | 2016-08-09 | Balance Therapeutics, Inc. | Derivados de pentilenotetrazol |
-
2015
- 2015-04-14 AU AU2015247829A patent/AU2015247829B2/en not_active Ceased
- 2015-04-14 JP JP2017506256A patent/JP6672264B2/ja not_active Expired - Fee Related
- 2015-04-14 US US15/303,725 patent/US10688103B2/en active Active
- 2015-04-14 CN CN201580031853.4A patent/CN106459066B/zh not_active Expired - Fee Related
- 2015-04-14 EP EP15780466.7A patent/EP3131904A4/en not_active Withdrawn
- 2015-04-14 WO PCT/US2015/025696 patent/WO2015160766A1/en not_active Ceased
- 2015-04-14 CA CA2945705A patent/CA2945705A1/en not_active Abandoned
- 2015-04-14 MX MX2016013340A patent/MX2016013340A/es unknown
- 2015-04-14 KR KR1020167031237A patent/KR20170005415A/ko not_active Ceased
- 2015-04-14 EA EA201692061A patent/EA201692061A1/ru unknown
-
2016
- 2016-10-09 IL IL248255A patent/IL248255A0/en unknown
- 2016-10-13 ZA ZA2016/07068A patent/ZA201607068B/en unknown
-
2019
- 2019-11-22 AU AU2019268190A patent/AU2019268190A1/en not_active Abandoned
-
2020
- 2020-03-04 JP JP2020036646A patent/JP2020105200A/ja active Pending
- 2020-05-06 US US16/868,365 patent/US20200360398A1/en not_active Abandoned
-
2022
- 2022-12-13 US US18/080,079 patent/US20230115839A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US10688103B2 (en) | 2020-06-23 |
| AU2019268190A1 (en) | 2019-12-12 |
| EA201692061A1 (ru) | 2017-03-31 |
| KR20170005415A (ko) | 2017-01-13 |
| US20180169107A1 (en) | 2018-06-21 |
| ZA201607068B (en) | 2023-01-25 |
| WO2015160766A1 (en) | 2015-10-22 |
| IL248255A0 (en) | 2016-11-30 |
| EP3131904A1 (en) | 2017-02-22 |
| CN106459066B (zh) | 2020-07-07 |
| EP3131904A4 (en) | 2017-11-22 |
| AU2015247829A1 (en) | 2016-10-27 |
| CN106459066A (zh) | 2017-02-22 |
| MX2016013340A (es) | 2017-02-09 |
| JP2017511386A (ja) | 2017-04-20 |
| JP2020105200A (ja) | 2020-07-09 |
| US20200360398A1 (en) | 2020-11-19 |
| AU2015247829B2 (en) | 2019-12-05 |
| JP6672264B2 (ja) | 2020-03-25 |
| US20230115839A1 (en) | 2023-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11648232B2 (en) | Methods and compositions for treating excessive sleepiness | |
| US11026944B2 (en) | Compositions and methods for treating insomnia | |
| US12077502B2 (en) | Formulations of T-type calcium channel modulators and methods of use thereof | |
| JP2009517393A (ja) | 不安症の治療方法 | |
| US20230115839A1 (en) | Methods For Treating Hypersomnia | |
| US20190298740A1 (en) | Methods and compositions for treating hallucinations and conditions related to the same | |
| KR20230004670A (ko) | 다리도렉산트의 의학적 용도 | |
| KR20250059489A (ko) | 조현병 및 기타 신경정신장애 및 신경학적 장애의 치료를 위한 환각물질 포함 조합물 | |
| CN119584962A (zh) | T型钙通道调节剂的使用方法 | |
| EP2891491A1 (en) | Use of (r)-phenylpiracetam for the treatment of sleep disorders | |
| JP6738797B2 (ja) | レット症候群治療薬 | |
| WO2024182654A1 (en) | High strength single unit dose formulations and methods of use thereof | |
| WO2025068765A1 (en) | Method of treating post-traumatic stress disorder | |
| HK40065333B (en) | Methods and compositions for treating sleep apnea | |
| HK40065333A (en) | Methods and compositions for treating sleep apnea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200414 |
|
| FZDE | Discontinued |
Effective date: 20221014 |
|
| FZDE | Discontinued |
Effective date: 20221014 |
|
| FZDE | Discontinued |
Effective date: 20221014 |